Announces U.S. Government Procurement Of Fetroja (Cefiderocol) Through Barda's Project Bioshield
28/08/2026 01:09
BRIEF-Shionogi & Co., Ltd. - Announces U.S. Government Procurement Of Fetroja (Cefiderocol) Through Barda's Project Bioshield Shionogi & Co., Ltd. 4507.T:
SHIONOGI & CO., LTD. - ANNOUNCES U.S. GOVERNMENT PROCUREMENT OF FETROJA (CEFIDEROCOL) THROUGH BARDA'S PROJECT BIOSHIELD
SHIONOGI & CO., LTD. - BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY’S PROJECT BIOSHIELD HAS EXERCISED A $36.9 MILLION PROCUREMENT OPTION, THE FIRST UNDER ITS CONTRACT WITH SHIONOGI
SHIONOGI & CO., LTD. - MONEY IS TO PROCURE FETROJA AS A COUNTERMEASURE AGAINST GRAM-NEGATIVE BACTERIAL INFECTIONS AND PATHOGENS
SHIONOGI & CO., LTD. - ORDER EXERCISES THE FIRST OF SEVERAL PROCUREMENT AND RELATED OPTIONS UNDER THE CONTRACT WITH INITIAL FUNDING OF $119 MILLION AND MULTIYEAR OPTIONS FOR A TOTAL OF UP TO $482 MILLION
Source text: ID:nTStb80c83
Further company coverage: 4507.T
Recent news on Shionogi & Co.
See all newsShionogi Continues Rare Disease Expansion With Planned Acquisition Of Intrabio Inc
Covgoze For Intramuscular Injection (Jn.1-Adapted), Recombinant Protein Covid-19 Vaccine, Receives Partial Change Approval In Japan
Notice Regarding Approval Of An Additional Dosage And Administration Of Vtama Cream For Pediatric Atopic Dermatitis (Under Age12) In Japan
Announces U.S. Government Procurement Of Fetroja (Cefiderocol) Through Barda's Project Bioshield
Media: Shionogi CEO pursues drug deals, mulls expanded US production - Bloomberg News